Genmab — Oktober 2018

[bibob]

[E_L]

JNJ cleaning up; also getting out of deal with Aduro https://endpts.com/jj-shrugs-off-deals-with-aduro-that-were-worth-up-to-1-2b-setback-forces-shift-to-novartis-alliance-now/

[E_L]

I guess that means Dara also works in prostate cancer #PositiveThinking

[Helge_LarsenPI-redaktør]

Dagens Mio-klub med Genmabsnak om den seneste kursudvikling. https://www.radio24syv.dk/programmer/millionaerklubben/36056757/nanosatellitter-cannabis-og-laks

[Solsen]

When JNJ left Geron and Imetelstat it was a positive sign. It could actualy mean that a huge unmet MDS (Myelodysplastisk syndrom) market is open to dara.

[Bulder]

Godt og vel det halve af MM-markedet. 13000 vs 24000 nye tilfælde i us hvert år. https://www.transparencymarketresearch.com/myelodysplastic-syndrome-treatment-market.html https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699489/

[Solsen]

Then we raise topsales from $10 to $16 bn

[JKY_VH]

[bibob]

Good hope instead of nohope.

[Bulder]

Nu vi er i gang, kan vi tillægge et par mia for amyloidosis - 3900 nye tilfælde i us.

[Solsen]

NKTCL samt ikke mindst RA.

[JKY_VH]

siger i, at vi er på vej mod $ 20 bn?

[Bulder]

Uha, med RA kan det vist ikke gøre det. WW >30mia $ i 2025. https://www.grandviewresearch.com/press-release/global-rheumatoid-arthritis-therapeutics-market

[Bulder]

Men nu skal vi første lige have dara i klinikken mod RA. Det er over et år siden de sendte IND.

[JKY_VH]

Wauw, ja jorden kalder

[bibob]

Ja, bare det ikke bliver en hård landing.

[Plimsoller]

God morgen

[henrik48]

God morgen

[bibob]

God morgen.

[bibob]

E L. - Yesterday on " aktiesnakken " 15.26 - 15.31 about Ofa. Seems like there are something. Study status Okt. 1 2018 " Met criteria "